20 articoli
A large cohort study finds HMOs have age-dependent, structure-specific effects on infant gut bacteria that persist to 13 months.
Human milk oligosaccharides shape beneficial gut bacteria in infants, providing lifelong protection against infections and chronic diseases.
Una revisione fondamentale rivela come i composti bioattivi del latte materno programmino il microbiota intestinale, l'immunità e il rischio di malattie a lungo termine nel neonato.
A 6-week RCT shows 2′-fucosyllactose raises Bifidobacterium, HDL, insulin, and FGF21 in adults over 60, with cognitive benefits in responders.
New lipidomics research reveals breast milk positions DHA and palmitic acid differently than maternal or fetal blood, suggesting a purposeful metabolic design.
Study shows 2'-fucosyllactose improves cognitive function in mice by modulating gut microbiota and brain serotonin levels.
New research reveals oxytocin signals fat cells to release lipids for milk, reshaping our understanding of lactation biology.
CGM data reveals infants fed corn syrup solid-based formulas show significantly greater glycemic variability than those fed breast milk or lactose-based formula.
I microarray di glicani sintetici rivelano come i sistemi immunitari umano e murino rispondono a *Candida*, identificando i principali oligosaccaridi bersaglio per la diagnostica e i vaccini.
L'oligosaccaride H3N2b raggiunge una precisione diagnostica del 100% nel plasma e nel liquido cerebrospinale e si riduce con la terapia genica AAV9 — una svolta per questa malattia cerebrale fatale.
A fetal enzyme floods newborns with hyocholic acids that train immune tolerance and shape a healthy gut microbiome—then disappear by adulthood.
SLC35A2-CDG disrupts ganglioside synthesis, not just protein glycosylation. Galactose supplementation restores lipid glycosylation and may explain neurological benefits.
Meno del 2% dell'acarbose viene assorbito dalla madre, rendendo l'esposizione del neonato attraverso il latte materno estremamente improbabile.
New research reveals that solid food source affects gut bacteria differently depending on whether babies are breastfed or formula-fed.
Comprehensive review reveals how infant gut bacteria development in first 1000 days determines chronic disease risk throughout life.
New research reveals which plant milk delivers superior cholesterol reduction and disease-fighting compounds for optimal health.
120-person trial tested whether Oligonol could reduce muscle loss and cardiovascular risks in middle-aged and older adults.
Study reveals how beneficial bacteria travel from gut to ovaries, improving reproductive function and delaying aging in laying hens.
New research reveals distinct patterns of intestinal microbiome development in mice, with implications for understanding human infant gut health.
La profilazione degli N-glicani plasmatici distingue la SM dalla NMOSD con anticorpi anti-AQP4 e dalla MOGAD con un'accuratezza fino all'80,5%, offrendo un complemento diagnostico non invasivo.
